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Abstract
By using mRNA differential display technology, we have identified three cDNA clones, myl 3, myl 4, and myl 6, to show
significant changes in expression between human colorectal tumor and paired normal tissue. Northern blot analysis indicated
that clone myl 3 expression was elevated in normal tissue, and clone myl 4 expression was elevated in tumor tissue.
Nucleotide sequence analysis revealed that clones myl 3 and myl 4 have not been previously identified. However, clone myl 6
appears to be the human homolog of the 3P end region of tissue inhibitor of metalloproteinase 3 (TIMP-3). Northern blot
analysis showed that a 2.5 kb TIMP-3 transcript was expressed at a much higher level in normal tissue than the colorectal
tumor. ß 1998 Elsevier Science B.V. All rights reserved.
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Searching for colorectal cancer-speci¢c biomarkers
has been an important issue, since such markers will
shed light on early detection, prognosis, and treat-
ment of the disease. The tests for occult blood in the
feces are widely used to screen for colorectal cancer.
However, better means of diagnosis and prognosis
for patients with colorectal cancer are needed to im-
prove the survival rate, and e⁄ciency of postopera-
tive adjuvant therapy [1,2]. Colorectal cancer results
from the accumulation of several distinct genetic al-
terations involving chromosomal translocations, gene
ampli¢cations and point mutations in oncogenes and
suppressor genes [3^6]. In a recent study, an increas-
ing expression of the ras oncogene and partial dele-
tion of p53 gene in colorectal tumor tissue has been
reported [7^9]. Also, a comprehensive study of hu-
man cancer done by Goldstein et al. showed that
colon cancer had relatively high multiple drug-resist-
ant gene (mdr) expression [10]. However, early detec-
tion of colorectal cancer by monitoring ras, p53, and
mdr expression levels are still unsatisfactory due to
either their low sensitivity or low speci¢city.
In this study, we used mRNA di¡erential display
reverse transcription^polymerase chain reaction
(DDRT^PCR) [11,12] to search for the genes that
are di¡erentially expressed in colorectal tumor and
paired normal tissues, and evaluated whether they
are useful as potential biomarkers for colorectal can-
cer.
The expression of mRNA in colorectal tumor clas-
si¢ed as a Dukes’ D stage and paired normal tissue
were analyzed using combinations of 40 random 10-
mers and three T11N primers. Each primer combina-
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tion displayed 80^150 bands, allowing approximately
10 000 di¡erent mRNA species to be screened in this
study. As shown in Fig. 1, 12 candidate clones ex-
hibited di¡erences in their expression between nor-
mal and colorectal tumor tissues. These changes were
con¢rmed by repeating the PCR and di¡erential dis-
play procedures.
The isolated clones from the display gel were
reampli¢ed by PCR, and were subcloned into
pGEM-T vector, and the clones were used as probes
for Northern blot analysis. By Northern blot analysis
using total RNA extracted from tissue samples, three
clones (myl 3, myl 4, and myl 6) were found to hy-
bridize with genes which were di¡erentially expressed
between normal and colorectal tumor tissues. As
shown in Fig. 2, two transcripts (1.7 kb and 3.2
kb) probed by clone myl 3 were present in normal
tissue but not in tumor tissue. Two transcripts (1.8
kb and 3.4 kb) probed by clone myl 4 were present in
tumor tissue but not in normal tissue. When clone
myl 6 was used as a probe, two predominant tran-
scripts (4.5 kb and 5.5 kb) were found to have the
same levels of expression in both normal and tumor
tissues. However, two other transcripts (1.7 kb and
2.5 kb) were found to have much higher levels in
normal tissue than in tumor tissue. Several possibil-
ities can explain the occurrence of multiple tran-
scripts, including alternative utilization of polyadeny-
lation sites, alternative splicing of the message, or the
presence of extended 5P untranslated regions. The
availability of full length of those cDNA clones
and the future availability of large amounts of color-
ectal tumor samples will allow studies to determine if
these novel genes or their coding proteins can be the
biomarkers for colorectal cancer.
The nucleotide sequences of clones myl 3, myl 4,
and myl 6 are shown in Fig. 3. Both myl 3 and myl 6
clones have variant polyadenylation signals. A search
of GenBank/EMBL databases revealed that clone
myl 6 had 98% homology to the tissue inhibitor of
metalloproteinase 3 (TIMP-3) [14,15]. The sequence
of cDNA fragment is limited because of primer de-
Fig. 1. Autoradiogram of di¡erential mRNA display of candi-
date clones. Total DNA-free RNA was isolated from tissue by
TRIzol reagent-chloroform (Gibco) extraction [13], and was re-
verse transcribed in 1UMMLV bu¡er which contained 2 WM of
either T11A, T11G, or T11C as the 3P-primer oligonucleotide
and Superscript-II (Gibco). After RT reaction, PCR was per-
formed by adding dNTPs, 5 WCi [35S]dATP, T11N oligonucleo-
tide, multiple arbitrary 10-mer oligonucleotide sets (Genosys Bi-
otechnologies), and Taq DNA polymerase (Promega). PCR
reactions were performed in the Rapidcycler (Idaho Technol-
ogy) at 94‡C for 30 s and 40 cycles at 94‡C for 2 s, 40‡C for
40 s, 72‡C for 30 s, followed by 72‡C for 5 min. PCR products
were electrophoresed on 6% acrylamide DNA sequencing gels
under denaturing conditions. Twelve candidate cDNA frag-
ments which show altered expression by di¡erential mRNA dis-
play are marked by arrowheads and were selected for subclon-
ing. Lane N indicates normal tissue; lane T indicates tumor
tissue.
Fig. 2. Northern blot analysis using [32P]dATP-labeled cDNA
probe derived from PCR reampli¢cation of clones myl 3, myl
4, and myl 6. The same blots reprobed with human glyceralde-
hyde-3-phosphate (GAPDH) cDNA as a loading control. Each
lane represents 10 Wg of total cytoplasmic RNA isolated from
normal or tumor tissue. Arrows indicate the position of tran-
scripts present in colorectal tissues.
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signs inherent to the DDRT^PCR method that result
in production of short cDNA sequences hybridized
with the 3P end region of target genes. Therefore, the
lack of homology for myl 3 and myl 4 clones with
known sequences does not eliminate the possibility
that they may be homologous to known genes or
gene families, since non-coding 3P regions of
mRNA species show great species to species varia-
tion. Further work to clone the full-length cDNAs of
these genes is needed to clarify the identity of nucleo-
tide sequences and to speculate regarding their func-
tions in colorectal tumorigenesis.
To con¢rm the di¡erential expression of TIMP-3
between human colorectal tumor and normal tissues,
a cDNA speci¢c for TIMP-3 open reading frame
fragment (390^791 bp) generated by RT^PCR from
total RNA of colon tissue was used as a probe in the
Northern blot analysis. It was observed that tran-
script 2.5 kb was predominantly present in the nor-
mal tissues but poorly expressed in tumor tissues
(Fig. 4). We speculated that the di¡erent transcript
pattern observed from the Northern blot analysis by
using a downstream DNA region (myl 6) and a
DNA open reading frame region as probes was due
to alternative splicing of the TIMP-3 gene.
TIMP-3 has been reported to inhibit collagenases
and gelatinases [14,15]. Metalloproteinases are able
to degrade the di¡erent components of extracellular
matrix, thereby facilitating tumor growth, invasion,
and metastasis [16,17]. Therefore, overproduction of
TIMP-1 and TIMP-2, members of the TIMP family,
could suppress tumor metastasis in vitro and in vivo
[18,19]. Conversely, down-regulation of TIMP-1 by
antisense RNA converts non-tumorigenic cells into
malignant cells [20]. Although the analysis of
TIMP-3 di¡erential expression is more con¢rmatory
than novel expression [21^23], in the present study
Fig. 3. Nucleotide sequence of clones myl 3, myl 4, and myl 6. DNA sequencing was performed directly from the TA cloning vector
using Sequenase version 2.0 kit (US Biochemical). T7 and SP6 promoter primers were used to locate the cloned insert. DNA sequen-
ces were analyzed by the FASTA search program of GCG package and were screened for homology against the GenBank/EMBL da-
tabase sequences. All contain a poly A tail and a variant polyadenylation signal (underlined) except clone myl 4.
Table 1
Incidence of gene expression in ten colorectal tumors and nor-
mal colorectal tissues by using clone myl 3, myl 4, and TIMP-3
cDNA fragment (401 bp) as probes
myl 3 myl 4 TIMP-3
Tumor 2/10 (20%) 7/10 (70%) 0/10
Normal 8/10 (80%) 0/10 6/10 (60%)
Colorectal tumor samples were collected at surgery. Samples
were dissected into two parts; one was for routine histopatho-
logical evaluation, the other was frozen immediately in liquid
nitrogen after surgical resection and maintained at 370‡C until
RNA extraction. The paired normal colon tissue samples were
dissected at locations 10 cm away from tumors.
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the 2.5 kb TIMP-3 gene expressed at a higher level in
normal tissue than in colorectal tumor is novel. Fur-
ther studies are needed to clarify the mechanism of
action of TIMP-3 and cellular physiological conse-
quences of altered TIMP-3 expression in colorectal
cancer metastasis.
In a study of ten colorectal carcinomas, we used
clones TIMP-3 cDNA, myl 3, and myl 4 as probes
for Northern blot analysis. Tumor tissues and
matched normal colon tissues were obtained from
ten consecutive, non-selected patients (six males
and four females) whose age ranged from 45 to 66
years old. Of the ten carcinoma tissues, three were
primary tumors and seven were from metastasis to
the liver. A pathological diagnosis of each tumor was
performed according to the criteria proposed by the
World Health Organization and UICC. The result
showed that the probe myl 4 detected gene expres-
sion in seven tumors (70%) but did not detect any
expression in the corresponding normal colorectal
tissue (Table 1). On the other hand, we detected
high gene expression in eight normal colorectal tis-
sues (80%) and only weak gene expression in two
tumors by using clone myl 3 as a probe. By using
TIMP-3 cDNA fragment as a probe, Northern blot
analysis showed that a 2.5 kb gene was highly ex-
pressed in six normal tissues but not in the corre-
sponding tumor tissues.
In conclusion, although the fundamental questions
related to function of those genes in tumorigenesis
are not answered, TIMP-3, myl 3, and myl 4 hybri-
dized genes can begin to be assessed for possible use
in clinical diagnosis. At the current stage, we are
conducting a large pilot study by using these novel
genes as probes to evaluate their potential to be used
as biomarkers for colorectal cancer.
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